Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Chongqing Lihong Fine Chemicals is a specialized chemical manufacturer based in Chongqing, China, focusing on cellulose ether products. Founded in 2001, the company has grown into a significant supplier of Sodium Carboxymethyl Cellulose (CMC) and Polyanionic Cellulose (PAC). Within the life sciences sector, the company provides pharmaceutical-grade CMC that meets international standards such as USP, BP, and EP. These products are essential excipients used in the pharmaceutical industry for tablet binding, disintegration, and stabilization of liquid dosage forms. The company operates advanced manufacturing facilities with a strong emphasis on quality control and environmental management. Its products are distributed globally, serving diverse markets including food, personal care, and industrial applications alongside its core pharmaceutical offerings.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Chongqing Lihong Fine Chemicals.